Antibodies Now Available Directly From the Source
News Dec 14, 2005
Monoclonal and polyclonal antibodies in lung and muscle development have recently been made available from Seven Hills Bioreagents (SHB), a venture of Cincinnati Children's Research Foundation (CCRF), directly from its web site.
SHB claims that, because the reagents available from SHB are supplied by expert researchers who are actively using them in their own laboratories, SHB is able to provide unprecedented product support.
Dr. Clarissa Naftzger, an immunologist with extensive background in biotechnology, was hired in 2003 to spearhead this initiative.
"This is a novel initiative for our research institution that should directly benefit research programs at Cincinnati Children's Hospital while providing valuable tools to scientists throughout the world," Naftzger said.
"Many of the antibodies we’re now supplying directly have been sold through third parties for years," she added.
Additionally, a Scientific Advisory Board composed of leading scientists in the Cincinnati medical research community is providing guidance on the development of new products.
"This new enterprise is an alternative commercial strategy to traditional licensing agreements," said Joseph Fondacaro, Ph.D., Director of CCRF’s Office of Intellectual Property.
In a new study in cells, University of Illinois researchers have adapted CRISPR gene-editing technology to cause the cell’s internal machinery to skip over a small portion of a gene when transcribing it into a template for protein building. This gives researchers a way not only to eliminate a mutated gene sequence, but to influence how the gene is expressed and regulated.
Researchers published today a detailed description of the complete genome of bread wheat, the world's most widely-cultivated crop. This work will pave the way for the production of wheat varieties better adapted to climate challenges, with higher yields, enhanced nutritional quality and improved sustainability.